Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
June 30, 2025
Via
NewMediaWire
Tickers
UNCY
Exposures
Product Safety
Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
June 30, 2025
Via
TheNewswire.com
Tickers
UNCY
Exposures
Product Safety
AINewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’
June 30, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
LTRN
Exposures
Artificial Intelligence
Product Safety
FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls
June 30, 2025
Via
Benzinga
Tickers
ARGX
Exposures
Product Safety
Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain
June 30, 2025
Via
Benzinga
Tickers
INMB
Exposures
Product Safety
FDA Raises Manufacturing Concerns, Delays Unicycive's Kidney Disease Drug Approval
June 30, 2025
Via
Benzinga
Tickers
UNCY
Exposures
Product Safety
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
June 30, 2025
Via
Investor Brand Network
Tickers
CLNN
SAP
Exposures
Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit - RCKT
June 30, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
RCKT
Exposures
Financial
Legal
Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit - RCKT
June 30, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
RCKT
Exposures
Financial
Legal
Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Added to Russell 3000 and Russell 2000 Indexes
June 30, 2025
Via
Investor Brand Network
Tickers
TNXP
Exposures
Product Safety
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
June 30, 2025
Via
Benzinga
Tickers
ACLX
AUTL
BMY
CABA
Exposures
Product Safety
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial
June 30, 2025
Via
Stocktwits
Tickers
AVUS
COIN
EAOR
MRNA
Exposures
Product Safety
Larry Page Rejected Steve Jobs' 'Do One Thing' Well Advice, Built Everything Instead: Palo Alto CEO Nikesh Arora Recalls Google's 'Product-Obsessed' Roots
June 30, 2025
Via
Benzinga
Topics
Product Recall
Tickers
AAPL
GOOG
GOOGL
PANW
Exposures
Legal
Product Safety
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost
June 30, 2025
Via
Stocktwits
Tickers
OMER
Exposures
Product Safety
Gilead’s Yeztugo HIV Shot Poised For Wider Reach After SCOTUS Ruling On Preventive Coverage: Wells Fargo
June 30, 2025
Via
Stocktwits
Tickers
GILD
MS
WFC
Exposures
Product Safety
Clark Smith, President of Golden Years Financial, Interviewed on The Influential Entrepreneurs Podcast Discussing Retirement Challenges
June 27, 2025
Via
Get News
Topics
Economy
Product Recall
Retirement
Exposures
Interest Rates
Legal
Pension
Clark Smith, President of Golden Years Financial, Interviewed on The Influential Entrepreneurs Podcast Discussing Retirement Challenges
June 27, 2025
Via
Authority Press Wire
Topics
Economy
Product Recall
Retirement
Exposures
Interest Rates
Legal
Pension
FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers
June 27, 2025
Via
Benzinga
Tickers
BMY
Exposures
Product Safety
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
June 27, 2025
Via
Investor Brand Network
Topics
Economy
Intellectual Property
Tickers
NRXP
Exposures
Intellectual Property
Product Safety
Supply Chain
SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half
June 27, 2025
Via
NewMediaWire
Topics
Death
Tickers
ICU
Exposures
Death
Product Safety
SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half
June 27, 2025
Via
TheNewswire.com
Topics
Death
Tickers
ICU
Exposures
Death
Product Safety
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
June 27, 2025
Via
NewMediaWire
Tickers
ICU
Exposures
Product Safety
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
June 27, 2025
Via
TheNewswire.com
Tickers
ICU
Exposures
Product Safety
Surrogacy4All Releases 2025 Rankings of Top Surrogacy Agencies, Championing Transparency, and Ethical Care for Intended Parents
June 27, 2025
Via
Get News
Exposures
Product Safety
Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
June 27, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
RCKT
Exposures
Financial
Legal
Product Safety
Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
June 27, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
RCKT
Exposures
Financial
Legal
Product Safety
5 Revealing Analyst Questions From Royalty Pharma’s Q1 Earnings Call
June 27, 2025
Via
StockStory
Topics
Earnings
World Trade
Exposures
Financial
Product Safety
Tariff
Experts Examine How Insurance May Adapt to Psychedelic-Assisted Therapy
June 27, 2025
Via
Press Release Distribution Service
Tickers
CI
Exposures
Product Safety
Incyte CEO Shake-Up Sparks M&A Buzz As RBC Analyst Highlights Meury’s Track Record: Retail Is All In
June 27, 2025
Via
Stocktwits
Topics
Intellectual Property
Tickers
AGN
INCY
NVS
RY
Exposures
Intellectual Property
Product Safety
CorMedix Stock Tumbles After $85M Stock Sale; But Retail Sees Bargain In DefenCath Bet
June 27, 2025
Via
Stocktwits
Tickers
CRMD
RY
TSX:RY
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.